---
title: 'Empowering Natural Killer Cells to Combat Acute Myeloid Leukemia: Perspective
  on CAR-NK Cell Therapy'
date: '2025-02-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39944413/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250213170915&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Acute myeloid leukemia (AML) is an aggressive hematologic
  malignancy with a high relapse rate and still limited therapeutic options. Natural
  killer (NK) cell-based immunotherapy has the potential to improve outcomes for patients
  with ...'
disable_comments: true
---
BACKGROUND: Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with a high relapse rate and still limited therapeutic options. Natural killer (NK) cell-based immunotherapy has the potential to improve outcomes for patients with ...